<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="28971">Ampicillin</z:chebi> and <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> have been used for initial empiric therapy of childhood <z:hpo ids='HP_0001287'>meningitis</z:hpo> since the mid-1970s </plain></SENT>
<SENT sid="1" pm="."><plain>Problems associated with these drugs include the possibility of <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi>-associated <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and the existence of Hemophilus influenzae type b resistance to both <z:chebi fb="1" ids="28971">ampicillin</z:chebi> and <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Several second- and third-generation <z:chebi fb="0" ids="23066">cephalosporins</z:chebi> have been shown to be as effective as <z:chebi fb="1" ids="28971">ampicillin</z:chebi> and <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> in the treatment of childhood <z:hpo ids='HP_0001287'>meningitis</z:hpo> </plain></SENT>
</text></document>